ALPHAPORT.AI
🇺🇸Pediatrix Medical Group, Inc.MD
USDUSD
SectorHealth CareIndustryProviders
Management
Mark S. Ordan
CEO

Company information

Ticker
MD
Country
United States
Sector
Health Care
Industry
Providers

Pediatrix Medical Group Business Summary

Pediatrix Medical Group, Inc. (NYSE: MD) operates a physician-led business model primarily generating revenue through fee-for-service professional fees for specialized maternal, neonatal, and pediatric healthcare services. The company’s primary business segments are concentrated in high-acuity, hospital-based care, including Neonatology (managing Neonatal Intensive Care Units), Maternal-Fetal Medicine (high-risk obstetrics), and various Pediatric Subspecialties such as cardiology and intensive care. Following a strategic restructuring that involved divesting non-core radiology and primary care practices, Pediatrix has refocused on its core clinical strengths to drive same-unit revenue growth and operational efficiency. Direct competitors include Select Medical Holdings, U.S. Anesthesia Partners, Sound Physicians, and TeamHealth; Pediatrix maintains a dominant market position as one of the nation’s largest providers of specialized newborn and maternal-fetal physician services, specifically targeting the approximately 25% of critically ill or premature infants born annually in the United States. Founded in 1979 by neonatologists Roger J. Medel, M.D., and Greg Melnick, Pediatrix is currently led by Chair and CEO Mark S. Ordan, who returned to the helm in January 2025 to accelerate the company’s strategic transformation. Ordan brings a distinguished pedigree in corporate turnarounds, having previously served as CEO of Sunrise Senior Living and Quality Care Properties, and holds an MBA from Harvard Business School. The executive leadership team includes Kasandra H. Rossi as EVP and Chief Financial Officer, Mary Ann E. Moore as EVP and General Counsel, and Greg Neeb as EVP and Chief Investment and Strategy Officer. The company’s governance is supported by a board featuring Lead Independent Director Guy P. Sansone and notable institutional backing from major investors such as Starboard Value, Vanguard, and BlackRock, reflecting its status as a significant publicly traded entity in the healthcare services sector.

Updated 2026-07-31 · US SEC company filings
Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.